IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Paradigm Biocapital Advisors LP

Portfolio Profile

CIK: 0001855655 | NEW YORK, NY

Investment Profile

Style

Aggressive Growth

Turnover

High

Orientation

Concentrated trader
$5.3B
AUM
28
Positions
75.21%
Top 10 Conc.
99.01%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Revolution Medicines Inc(RVMD)6,361,323$1.2B22.31%
2Nuvalent Inc(NUVL)5,924,433$731.7M13.70%
3Edgewise Therapeutics Inc(EWTX)10,215,455$415.1M7.77%
4Genmab A/S(GMAB)13,133,131$360.8M6.76%
5Spyre Therapeutics Inc(SYRE)3,840,778$341.0M6.38%
6

Sector Allocation

Latest filing, equity positions only

Healthcare99.14% · $5.3B
Unclassified0.86% · $46.0M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare98.7%99.14%+0.44%
Unclassified1.3%0.86%-0.44%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$1.5B | 31 pos.
$2.1B | 30 pos.
$2.8B | 34 pos.
$2.6B | 35 pos.
$3.0B | 33 pos.
$2.9B | 28 pos.
Apogee Therapeutics Inc(APGE)
1,576,385
$209.2M
3.92%
7Oruka Therapeutics Inc(ORKA)2,144,526$204.1M3.82%
8Tango Therapeutics Inc(TNGX)6,357,523$198.7M3.72%
9Belite BIO Inc(BLTE)1,232,877$189.8M3.55%
10Erasca Inc(ERAS)9,550,000$175.0M3.28%
Cap SizePrev %Curr %Change
Mid Cap68.44%51.32%-17.12%
Large Cap21.78%34.42%+12.64%
Small Cap8.39%12.46%+4.07%
Micro Cap0.08%0.94%+0.86%
Unclassified1.3%0.86%-0.44%
$2.2B | 28 pos.
$2.3B | 28 pos.
$3.5B | 36 pos.
$3.9B | 30 pos.
$4.9B | 35 pos.
$5.3B | 28 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

7
New
14
Closed
12
Increased
7
Decreased
2
Unchanged